XM
VYGR icon

XTX Markets’s Voyager Therapeutics VYGR Stock Holding History

XTX Markets’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$76K Buy
+10,578
New +$102K 0.16% 174

Other funds holding VYGR

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

XTX Markets's VYGR Position: Q4 2020 in Review

XTX Markets opened a new position in Voyager Therapeutics (VYGR) in Q4 2020: 10,578 shares worth $76K. The stake represents 0.16% of the portfolio and ranks #174 among its holdings.

101 funds tracked by Wall St. Rank hold VYGR as of Q4 2020.

  • XTX Markets held 10,578 shares of Voyager Therapeutics worth $76K as of Q4 2020.
  • Voyager Therapeutics was a new XTX Markets position in Q4 2020.
  • Voyager Therapeutics made up 0.16% of XTX Markets's portfolio in Q4 2020, its #174 holding.
  • 101 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q4 2020.

Based on XTX Markets's 13F filing for Q4 2020, filed 25 Jan 2021.